Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients

Mojtaba Akhtari, Vijaya Raj Bhatt, Pavan Kumar Tandra, Jairam Krishnamurthy, Heidi Horstman, Amy Dreessen, Pei Xian Chen, James O. Armitage

Research output: Contribution to journalReview article

17 Scopus citations

Abstract

AML, acute myeloid leukemia; ASCT, autologous hematopoietic stem cell transplantation; t-MN, therapy-related myeloid neoplasm; PBPC, peripheral blood progenitor cells; TBI, total body irradiation; XRCC1, X-ray repair cross-complementing 1; FISH, fluorescent in-situ hybridization, GVHD, graft-versus-host-disease; MDS, myelodysplastic syndrome; MTHFR, methylenetetrahydrofolate reductase, GSTM1, glutathione S-transferase mu 1; PTPRT, protein tyrosine phosphatase, receptor type; P72R, proline 72 arginine; BEAM, BCNU, etoposide, Ara-C and melphalan; NHL, non-Hodgkin lymphoma; MOPP, mechlorethamine, chlorambucil, cyclophosphamide, and lomustine; HL, Hodgkin lymphoma; NA, not available.

Original languageEnglish (US)
Pages (from-to)1077-1088
Number of pages12
JournalCancer Biology and Therapy
Volume14
Issue number12
DOIs
StatePublished - Dec 2013

Keywords

  • Acute myeloid leukemiautologous hematopoietic stem cell transplantation
  • Hodgkin lymphoma
  • Myelodysplasia
  • Non-Hodgkin lymphoma
  • Therapy-related myeloid neoplasms

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Fingerprint Dive into the research topics of 'Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients'. Together they form a unique fingerprint.

  • Cite this